HomeNDC LookupRxCUI directory › RxCUI 860707

24 HR galantamine hydrobromide 24 MG Extended Release Oral Capsule — RxCUI 860707

RxNorm drug concept · Semantic clinical drug
RxCUI 860707 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 29 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI860707
Official name24 HR galantamine hydrobromide 24 MG Extended Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asgalantamine HBr 24 MG 24HR Extended Release Oral Capsule
FDA products mapped8
Package NDCs mapped29
Reported Medicaid activity (SDUD)644 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Galantamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Galantamine helps boost a brain chemical called acetylcholine that Alzheimer's disease gradually depletes. This can help maintain memory and thinking for a period of time, but it d...
  • What exactly does galantamine do for Alzheimer's — will it stop the disease from getting worse?
  • Nausea and vomiting are the most common side effects, especially when the dose is being increased. The good news is that nausea usually only lasts about 5 to 7 days and tends to ge...
  • I heard galantamine can upset your stomach — is there anything I can do about that?
📖 Read our full Galantamine guide →

🕸️ Concept Web — How 24 HR galantamine hydrobromide 24 MG Extended Re... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR galantamine hydrobromide 24 MG Extended Release Oral Capsule RxCUI 860707

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Galantamine 4637
    • Galantamine hydrobromide 860693
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Galantamine Extended Release Oral Capsule 583097
    • Galantamine hydrobromide Extended Release Oral Capsule 2647095
    • Galantamine Oral Product 1163354
    • Galantamine Pill 1163355
    • Galantamine hydrobromide Oral Product 2661776
    • Galantamine hydrobromide Pill 2659824
    • Extended Release Oral Capsule 316943
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Galantamine hydrobromide 24 MG 860706

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Galantamine hydrobromide 24 MG SCDC · 860706
  • Galantamine Extended Release Oral Capsule SCDF · 583097
  • Galantamine hydrobromide Extended Release Oral Capsule SCDFP · 2647095
  • Galantamine Oral Product SCDG · 1163354
  • Galantamine Pill SCDG · 1163355
  • Galantamine hydrobromide Oral Product SCDGP · 2661776
  • Galantamine hydrobromide Pill SCDGP · 2659824

📦 FDA Products & Package NDCs

8 products · 29 package NDCs
29 package NDCs map to RxCUI 860707 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
47335-0835-08 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-835-08) Galantamine Hydrobromide Sun Pharmaceutical Industries, Inc. 2011-02-09
47335-0835-18 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-835-18) Galantamine Hydrobromide Sun Pharmaceutical Industries, Inc. 2011-02-09
47335-0835-83 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-835-83) Galantamine Hydrobromide Sun Pharmaceutical Industries, Inc. 2011-02-09
47335-0835-88 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-835-88) Galantamine Hydrobromide Sun Pharmaceutical Industries, Inc. 2011-02-09
47335-0836-08 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-836-08) Galantamine Hydrobromide Sun Pharmaceutical Industries, Inc. 2011-02-09
47335-0836-18 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-836-18) Galantamine Hydrobromide Sun Pharmaceutical Industries, Inc. 2011-02-09
47335-0836-83 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-836-83) Galantamine Hydrobromide Sun Pharmaceutical Industries, Inc. 2011-02-09
47335-0836-88 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-836-88) Galantamine Hydrobromide Sun Pharmaceutical Industries, Inc. 2011-02-09
47335-0837-08 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-837-08) Galantamine Hydrobromide Sun Pharmaceutical Industries, Inc. 2011-02-09
47335-0837-18 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-837-18) Galantamine Hydrobromide Sun Pharmaceutical Industries, Inc. 2011-02-09
47335-0837-83 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-837-83) Galantamine Hydrobromide Sun Pharmaceutical Industries, Inc. 2011-02-09
47335-0837-88 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-837-88) Galantamine Hydrobromide Sun Pharmaceutical Industries, Inc. 2011-02-09
63629-2363-01 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63629-2363-1) Galantamine Hydrobromide Bryant Ranch Prepack 2011-02-09
65862-0744-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-744-01) Galantamine Aurobindo Pharma Limited 2016-08-05
65862-0744-05 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-744-05) Galantamine Aurobindo Pharma Limited 2016-08-05
65862-0744-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-744-30) Galantamine Aurobindo Pharma Limited 2016-08-05
65862-0744-90 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-744-90) Galantamine Aurobindo Pharma Limited 2016-08-05
65862-0744-99 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-744-99) Galantamine Aurobindo Pharma Limited 2016-08-05
65862-0745-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-745-01) Galantamine Aurobindo Pharma Limited 2016-08-05
65862-0745-05 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-745-05) Galantamine Aurobindo Pharma Limited 2016-08-05
65862-0745-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-745-30) Galantamine Aurobindo Pharma Limited 2016-08-05
65862-0745-90 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-745-90) Galantamine Aurobindo Pharma Limited 2016-08-05
65862-0745-99 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-745-99) Galantamine Aurobindo Pharma Limited 2016-08-05
65862-0746-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-746-01) Galantamine Aurobindo Pharma Limited 2016-08-05
65862-0746-05 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-746-05) Galantamine Aurobindo Pharma Limited 2016-08-05
65862-0746-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-746-30) Galantamine Aurobindo Pharma Limited 2016-08-05
65862-0746-90 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-746-90) Galantamine Aurobindo Pharma Limited 2016-08-05
65862-0746-99 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-746-99) Galantamine Aurobindo Pharma Limited 2016-08-05
72162-1448-03 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72162-1448-3) Galantamine Hydrobromide Bryant Ranch Prepack 2011-02-09
Observed labelers: Aurobindo Pharma Limited (15) · Sun Pharmaceutical Industries, Inc. (12) · Bryant Ranch Prepack (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.